TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/14/22 08:40 | 11/10/22 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Dexcel Pharma Technologies Ltd. | L3 | T | P | 20,000 | 5.00 | 0 | 4,000 | 4 | 102,849 | D | |||||||||||||||
4/26/22 06:48 | 4/22/22 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Dexcel Pharma Technologies Ltd. | L3 | T | P.m | 155 | 3.85 | 0 | 40 | 0 | 98,849 | D | |||||||||||||||
6/3/21 17:40 | 6/2/21 | PLX | Protalix Biotherapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Dexcel Pharma Technologies Ltd. | L3 | T | S.m | -2,089 | 2.27 | 0 | -919 | -20 | 3,637 | D | |||||||||||||||
2/4/20 18:41 | 1/31/20 | NTEC | Intec Pharma Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Dexcel Pharma Technologies Ltd. | L3 | T | S.m | -282 | 0.3075 | 0 | -916 | -18 | 4,235 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |